Emmaus Life Sciences, Inc. EMMA
0.02 USD -0.01 (-31.51%)
Regular-session close
0.022 Day range 0.022
0.0084 52-week range 0.083
- YTD
- +15.38%
- 1 year
- +64.84%
EMMA revenue history
Revenue is income from the company’s ordinary business activities.
1,315,500 USD
FY 2018 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Some periods have no fiscal period label and are omitted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2018 | 2018-09-30 | 1,315,500 | 1,187,000 | 923.74% |
| FY 2017 | 2017-09-30 | 128,500 | 43,400 | 51.00% |
| FY 2016 | 2016-09-30 | 85,100 | -15,000 | -14.99% |
| FY 2015 | 2015-09-30 | 100,100 | -35,000 | -25.91% |
| FY 2014 | 2014-09-30 | 135,100 | 4,200 | 3.21% |
| FY 2013 | 2013-09-30 | 130,900 | 15,900 | 13.83% |
| FY 2012 | 2012-09-30 | 115,000 | 3,600 | 3.23% |
| FY 2011 | 2011-09-30 | 111,400 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:01:53.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.